Summary Info
Ticaret Sicil Tescili
Update Notification Flag
Yes
Correction Notification Flag
No
Postponed Notification Flag
No
Board Decision Date
14.10.2022
Authorized Capital (TL)
1.000.000.000
Paid-in Capital (TL)
125.000.000
Target Capital (TL)
250.000.000
Rights Issue (Via Preemptive Right)
Share Group Info
Paid-in Capital (TL)
Preemptive Rights Amount (TL)
Preemptive Rights Rate (%)
Preemptive Rights Price
Share Group Issued
New Shares'' ISIN
Form
Preemptive Rights ISIN Code
Unused Rights Amount (TL)
Amount of Shares Cancelled (TL)
A Grubu, İşlem Görmüyor, TREMEGA00029
9.573.615,77
9.573.615,770
100,00000
1,00
A Grubu
A Grubu, İşlem Görmüyor, TREMEGA00029
Registered
A Grubu, MEGA2(İMTİYAZLI RÜÇHAN), TRRMEGA00039
B Grubu, MEGAP, TREMEGA00011
115.426.384,23
115.426.384,230
100,00000
1,00
B Grubu
B Grubu, MEGAP, TREMEGA00011
Bearer
B Grubu, MEGAP(RÜÇHAN), TRRMEGA00047
1.125.862,371
Paid-in Capital (TL)
Preemptive Rights Amount (TL)
Preemptive Rights Rate (%)
Unused Rights Amount (TL)
Amount of Shares Cancelled (TL)
TOTAL
125.000.000
125.000.000,000
100,00000
1.125.862,371
Rights Issue Ex-Date
13.04.2023
Preemptive Rights Exercise End Date
27.04.2023
Currency Unit
TRY
Other Aspects To Be Notified
Number of Articles of Association Item To Be Amended
6
Capital Market Board Application Date Regarding Articles of Association
31.05.2023
Capital Market Board Application Result Regarding Articles of Association
APPROVAL
Capital Market Board Approval Date Regarding Articles of Association
16.06.2023
Capital Market Board Application Date
07.11.2022
Capital Market Board Application Result
Approval
Capital Market Board Approval Date
06.04.2023
Property of Increased Capital Shares
Dematerialized Share
Payment Date
17.04.2023
Record Date
14.04.2023
Date Of Registry
18.07.2023
Additional Explanations

İstanbul Ticaret Sicil Müdürlüğü'ne Sermaye Artırımının tescili için yapmış olduğumuz başvuru Sicil Müdürlüğünce tescil edilmiş ve 18.07.2023 tarih ve 10873 sayılı Ticaret Sicil Gazetesinde ilan edilmiştir.

Supplementary Documents
Appendix: 1
RP358.pdf